A Synergy of CAR-T Hematotoxicity Scoring Tools

Two scoring tools used to predict hematologic toxicity after chimeric antigen receptor T-cell (CAR-T) therapy demonstrated comparable overall accuracy in a single-center retrospective study, but a closer look at their performance revealed a meaningful difference that suggests each tool may be best suited to a different phase of patient care, according to study results (poster TR002).The study compared CAR-HEMATOTOX and KyoTox in 60 adults with B-cell lymphoma who received CD19-directed CAR-T the